MedTrace Logo

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer

NCT01305993 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2011-03-01

No results posted yet for this study

Summary

The purpose of this study is to determine efficacy of SB injection in Gastric Cancer.

Conditions

Interventions

DRUG

SB injection

Infusion SBinjection of 21.87ml/m\^2, IV route, 24times for 4 months

Sponsors & Collaborators

  • SBPharmaceutical IND, Co., LTD

    lead INDUSTRY

Principal Investigators

  • Yong-oon Shin, Prof · Inha University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305993 on ClinicalTrials.gov